Viewing Study NCT01582204

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2026-02-24 @ 2:16 AM
Study NCT ID: NCT01582204
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-05
First Post: 2012-04-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None clear cell carcinoma View
None Kidney View
None MAB-124I-CG250 View
None PET scan View
None CT scan View
None sunitinib View
None pazopanib View
None 11-134 View